p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading

被引：0
|
作者：
Emanuela Guerra
Alessia Cimadamore
Pasquale Simeone
Giovanna Vacca
Rossano Lattanzio
Gerardo Botti
Valentina Gatta
Marco D’Aurora
Barbara Simionati
Mauro Piantelli
Saverio Alberti
机构：
[1] University of Chieti,Unit of Cancer Pathology, CeSI
[2] University ‘G. D’Annunzio’,MeT
[3] National Cancer Institute,Department of Medical, Oral and Biotechnological Sciences
[4] University ‘G. D’Annunzio’,Department of Pathology “Foundation G.Pascale”
[5] BMR Genomics srl,Department of Psychological, Health ad Territorial Sciences, School of Medicine and Life Sciences
[6] University ‘G. D’Annunzio’,Department of Neurosciences, Imaging and Clinical Sciences
来源：
BMC Cancer | / 16卷
关键词：
Breast cancer; Metastatic relapse; Prognostic indicators; TP53; Bcl-2; Cathepsin D; RAS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Reciprocal expression of Bcl-2 and p53 in breast ductal carcinoma
    Lee, WY
    Jin, YT
    Tzeng, CC
    ANTICANCER RESEARCH, 1996, 16 (5A) : 3007 - 3012
  • [42] Immunohistochemical analysis of bcl-2 and p53 protein in breast carcinoma
    Baba, M
    Hideshima, T
    Shinohara, T
    Yamashita, JI
    Shirakusa, T
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 8 (02) : 355 - 358
  • [43] Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes
    Arun, B
    Kilic, G
    Yen, C
    Foster, B
    Yardley, D
    Gaynor, R
    Ashfaq, R
    CANCER, 2003, 98 (12) : 2554 - 2559
  • [44] Prognostic value of c-erbB2, P53 and bcl-2 immunoexpression in prostate cancer
    de Torres, I
    Morote, J
    Vallejo, C
    Vidal, MT
    MODERN PATHOLOGY, 1998, 11 (01) : 80A - 80A
  • [45] Prognostic significance of HER-2, p53 and Bcl-2 in patients with epithelial ovarian cancer
    Malamou-Mitsi, Vassiliki
    Crikoni, Olga
    Timotheadou, Eleni
    Aravantinos, Gerassimos
    Vrettou, Eleni
    Agnantis, Niki
    Fountzilas, George
    ANTICANCER RESEARCH, 2007, 27 (02) : 1157 - 1165
  • [46] bcl-2 and p53 in endometrial adenocarcinoma
    Taskin, M
    Lallas, TA
    Barber, HRK
    Shevchuk, MM
    MODERN PATHOLOGY, 1997, 10 (07) : 728 - 734
  • [47] Emerging role of p53, bcl-2 and telomerase activity in Egyptian breast cancer patients
    Swellam, M
    Ismail, M
    Eissa, S
    Hamdy, M
    Mokhtar, N
    IUBMB LIFE, 2004, 56 (08) : 483 - 490
  • [48] The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer
    Rolland, Phil
    Spendlove, Ian
    Madjid, Zahra
    Rakha, Emad A.
    Patel, Poulam
    Eljis, Ian O.
    Durrant, Lindy
    INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (06) : 1311 - 1317
  • [49] Prognostic significance of bcl-2 and p53 expression in colorectal carcinoma.
    Zhao D.P.
    Ding X.W.
    Peng J.P.
    Zheng Y.X.
    Zhang S.Z.
    Journal of Zhejiang University SCIENCE B, 2005, 6 (12): : 1163 - 1169
  • [50] Expression of p53 and bcl-2 in cholangiocarcinomas
    Arora, DS
    Wyatt, JI
    JOURNAL OF PATHOLOGY, 1997, 182 : A35 - A35
12345